WHAT DOCTORS HAVE TO SAY
Hear from some of the world's most renowned blood cancer doctors and researchers
about how LLS and C3 support helps their work.
CARL JUNE, M.D.
Fire With Fire
Dr. Carl June is the director of translational research at the Abramson Cancer Center at the University of Pennsylvania. He is best known for his research into T-cell therapies for treatment of cancer.
BRIAN DRUKER, M.D.
Why LLS Is Your Best Investment
Dr. Brian Druker is Director of the Knight Cancer Institute, Oregon Health & Sciences University. Dr. Druker is a pioneer in the field of precision medicine and revolutionized cancer treatment turning a once-fatal cancer, Chronic Myeloid Leukemia, into a manageable condition through his research and development of Gleevec.
KEN ANDERSON, M.D.
The Impact of LLS on Cancer Research
Dr. Kenneth Anderson is an American hematologist - oncologist and cancer researcher who is primarily known for advances in the treatment of multiple myeloma. He directs the Lebow Institute for Myeloma Therapeutics and Jerome Lipper Myeloma Center at Dana-Farber Cancer Institute.